Lenalidomide and dexamethasone (LEN plus DEX) treatment in relapsed/refractory multiple myeloma (RRMM) patients (pts) and risk of second primary malignancies (SPM): Analysis of MM-009/010.

Article2011

Long-Term Outcomes and Safety of Continuous Lenalidomide Plus Dexamethasone (Len+Dex) Treatment in Patients (Pts) with Relapsed or Refractory Multiple Myeloma (RRMM)

Meletios A Dimopoulos, Mohamad A. Hussein, Arlene S. Swern, Donna M. Weber

Article2011

A randomized, multicenter, phase (Ph) III study comparing carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (Dex) to LEN and Dex in patients (Pts) with relapsed multiple myeloma (MM).

Philippe Moreau, Antonio Palumbo, A. Keith Stewart, S. Vincent Rajkumar, Andrzej Jakubowiak, Kathleen G. Halka, Vesselina Goranova‐Marinova, Horia Bumbea, Kelly Pendergrass, Anca Roxana Lupu, Meletios A Dimopoulos, Albert Oriol Rocafiguera, J. G. Gandhi, Georgi Mihaylov, Tamás Masszi, J. Matous, Gustavo Fonseca, Richard Bryce, David S. Siegel

Article2009

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

Meletios A Dimopoulos, Christine Chen, Andrew Spencer, Rubén Niesvizky, Michel Attal, Edward A. Stadtmauer, Maria Teresa Petrucci, Zhinuan Yu, Marta Olesnyckyj, Jerome B. Zeldis, Robert Knight, D. Weber

Article2015

ELOQUENT-2: A phase III, randomized, open-label study of lenalidomide (Len)/dexamethasone (dex) with/without elotuzumab (Elo) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).

Sagar Lonial, Meletios A Dimopoulos, Antonio Palumbo, Darrell White, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Philippe Moreau, María‐Victoria Mateos, Hila Magen‐Nativ, Andrew R. Belch, Donna Reece, Meral Beksaç, Masafumi Taniwaki, Christoph Röllig, Anil Singhal, Jessica Katz, Eric Bleickardt, Valerie Poulart, Paul G. Richardson

Article2005

Study of Lenalidomide Plus Dexamethasone Versus Dexamethasone Alone in Relapsed or Refractory Multiple Myeloma (MM): Results of a Phase 3 Study (MM-010).

Meletios A Dimopoulos, Andrew Spencer, Michael Attal, Miles Prince, Jean‐Luc Harousseau, Anna Dmoszyńska, Zhinuan Yu, Marta Olesnyckyj, Jerome B. Zeldis, Robert Knight

Abstract

Discussion(0)

Related publications